René Hen

Title: Innovations and Contributions of Inventor René Hen

Introduction

René Hen is a notable inventor based in Tenafly, NJ (US). He has made significant contributions to the field of pharmacology and gene regulation, holding a total of 2 patents. His work focuses on developing methods to address stress-induced affective disorders and innovative gene manipulation techniques.

Latest Patents

Hen's latest patents include groundbreaking research on pharmacological prophylactics against stress-induced affective disorders. This patent outlines methods for treating stress-induced psychopathology by administering an effective amount of an antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptor, such as ketamine, prior to a stressor. Additionally, he has developed a FAST (Flexible Accelerated STOP TetO-knockin) system for in vivo gene regulation. This system allows for efficient manipulation of gene expression, enabling rapid screening of animal models for various diseases. It demonstrates flexibility and broad applicability by targeting genes implicated in neuropsychiatric disorders.

Career Highlights

René Hen is affiliated with Columbia University, where he conducts his research and develops his innovative ideas. His work has garnered attention for its potential impact on understanding and treating mental health disorders.

Collaborations

Hen collaborates with esteemed colleagues, including Rebecca Anne Brachman and Christine Ann Denny, who contribute to his research endeavors.

Conclusion

René Hen's contributions to pharmacology and gene regulation highlight his innovative spirit and dedication to advancing scientific knowledge. His patents reflect a commitment to addressing critical health issues and improving treatment methodologies.